{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:44:46Z","timestamp":1788558286195,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.peptides.2021.170526","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T16:23:49Z","timestamp":1614961429000},"page":"170526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Antiviral peptides against Coronaviridae family: A review"],"prefix":"10.1016","volume":"139","author":[{"given":"Hamid","family":"Heydari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Golmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mirnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Tebyanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fasihi-Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Moosazadeh Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2021.170526_bib0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41564-020-0709-x","article-title":"The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks","volume":"5","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.peptides.2021.170526_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41392-020-0190-2","article-title":"Overview of lethal human coronaviruses","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.peptides.2021.170526_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vey035","article-title":"Identification and characterization of Coronaviridae genomes from Vietnamese bats and rats based on conserved protein domains","volume":"4","author":"Phan","year":"2018","journal-title":"Virus Evol."},{"key":"10.1016\/j.peptides.2021.170526_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.peptides.2021.170526_bib0025","doi-asserted-by":"crossref","first-page":"198045","DOI":"10.1016\/j.virusres.2020.198045","article-title":"Porcine epidemic diarrhea virus (PEDV): an update on etiology, transmission, pathogenesis, and prevention and control","volume":"286","author":"Jung","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0030","series-title":"Avian Infectious Bronchitis Virus: Recent Advances in Animal Virology","first-page":"301","author":"Ramakrishnan","year":"2019"},{"key":"10.1016\/j.peptides.2021.170526_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fvets.2019.00053","article-title":"Porcine hemagglutinating encephalomyelitis virus: a review","volume":"6","author":"Mora-D\u00edaz","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.peptides.2021.170526_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fvets.2019.00034","article-title":"PEDV and PDCoV Pathogenesis: The interplay between host innate immune responses and porcine enteric coronaviruses","volume":"6","author":"Koonpaew","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.peptides.2021.170526_bib0045","doi-asserted-by":"crossref","first-page":"197843","DOI":"10.1016\/j.virusres.2019.197843","article-title":"Swine acute diarrhea syndrome coronavirus (SADS-CoV) antagonizes interferon-\u03b2 production via blocking IPS-1 and RIG-I","volume":"278","author":"Zhou","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0050","article-title":"Transmissible gastroenteritis virus of pigs and porcine epidemic diarrhea virus: reference Module in Life Sciences","author":"Liu","year":"2019","journal-title":"Encyclopedia Virol."},{"key":"10.1016\/j.peptides.2021.170526_bib0055","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00018-019-03138-w","article-title":"Antiviral peptides as promising therapeutic drugs","volume":"76","author":"Vilas Boas","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.peptides.2021.170526_bib0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.peptides.2021.170526_bib0065","doi-asserted-by":"crossref","first-page":"367243","DOI":"10.1155\/2015\/367243","article-title":"Antimicrobial peptides: current and potential applications in biomedical therapies","volume":"2015","author":"L\u00f3pez-Meza","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.peptides.2021.170526_bib0070","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1099\/jmm.0.000524","article-title":"In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis","volume":"66","author":"Mohammadi Azad","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.peptides.2021.170526_bib0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MRM.0000000000000032","article-title":"The development of antimicrobial peptides as an approach to prevention of antibiotic resistance","volume":"26","author":"Moghaddam","year":"2015","journal-title":"Rev. Med. Microbiol."},{"key":"10.1016\/j.peptides.2021.170526_bib0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000494354","article-title":"Antiviral activity of synthetic peptides derived from physiological proteins","volume":"61","author":"Sala","year":"2018","journal-title":"Intervirology"},{"key":"10.1016\/j.peptides.2021.170526_bib0085","first-page":"1","article-title":"Antiviral eptides: identification and alidation","author":"Agarwal","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.peptides.2021.170526_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jiph.2017.08.009","article-title":"Current treatment options and the role of peptides as potential therapeutic components for Middle East respiratory syndrome (MERS): a review","volume":"11","author":"Mustafa","year":"2018","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.peptides.2021.170526_bib0095","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/mdr.2017.0392","article-title":"Antimicrobial peptides: features, action, and their resistance mechanisms in bacteria","volume":"24","author":"Moravej","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.peptides.2021.170526_bib0100","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.jmb.2018.06.024","article-title":"Virus-receptor interactions: the key to cellular invasion","volume":"430","author":"Maginnis","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.peptides.2021.170526_bib0105","doi-asserted-by":"crossref","first-page":"104792","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers a potential target for antiviral development","volume":"178","author":"Tang","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0110","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.3390\/ijms21113843","article-title":"Broad-spectrum coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus diseases","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.peptides.2021.170526_bib0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/135965350501000301","article-title":"Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus","volume":"10","author":"Zheng","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.peptides.2021.170526_bib0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virol.2006.01.029","article-title":"Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor","volume":"350","author":"Han","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2021.170526_bib0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2005.10.005","article-title":"Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction","volume":"69","author":"Ho","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2014.01.022","article-title":"Cell adhesion as a novel approach to determining the cellular binding motif on the severe acute respiratory syndrome coronavirus spike protein","volume":"201","author":"Chang","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.peptides.2021.170526_bib0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.antiviral.2011.12.012","article-title":"A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2","volume":"94","author":"Struck","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40268-020-00312-5","article-title":"Identification of a potential peptide inhibitor of SARS-CoV-2 targeting its entry into the host cells","volume":"20","author":"Baig","year":"2020","journal-title":"Drugs R D"},{"key":"10.1016\/j.peptides.2021.170526_bib0145","doi-asserted-by":"crossref","first-page":"e0240004","DOI":"10.1371\/journal.pone.0240004","article-title":"In-silico design of a potential inhibitor of SARS-CoV-2 S protein","volume":"15","author":"Jaiswal","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170526_bib0150","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/molpharm.120.000098","article-title":"Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection","volume":"98","author":"Tavassoly","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170526_bib0155","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/j.gastro.2020.05.015","article-title":"Human intestinal defensin 5 inhibits SARS-CoV-2 invasion by cloaking ACE2","volume":"159","author":"Wang","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.peptides.2021.170526_bib0160","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.peptides.2021.170526_bib0165","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(04)15788-7","article-title":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors","volume":"363","author":"Liu","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2021.170526_bib0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2180-3-20","article-title":"Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy","volume":"3","author":"Kliger","year":"2003","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.peptides.2021.170526_bib0175","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virusres.2006.03.001","article-title":"Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein","volume":"120","author":"Sainz","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0180","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2004.05.046","article-title":"Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein","volume":"319","author":"Yuan","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170526_bib0185","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/jcb.21790","article-title":"Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors","volume":"104","author":"Chu","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.peptides.2021.170526_bib0190","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/JVI.01697-07","article-title":"Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway","volume":"82","author":"Ujike","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2021.170526_bib0195","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/JVI.02322-09","article-title":"Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae","volume":"84","author":"O\u2019Keefe","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2021.170526_bib0200","doi-asserted-by":"crossref","first-page":"22008","DOI":"10.1038\/srep22008","article-title":"A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2021.170526_bib0205","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/ncomms4067","article-title":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor","volume":"5","author":"Lu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.peptides.2021.170526_bib0210","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/infdis\/jiv325","article-title":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV Infection","volume":"212","author":"Channappanavar","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.peptides.2021.170526_bib0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/v9090255","article-title":"Identification of a novel inhibitor against Middle East respiratory syndrome coronavirus","volume":"9","author":"Sun","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.peptides.2021.170526_bib0220","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/acs.jmedchem.7b01732","article-title":"Discovery of hydrocarbon-stapled short \u03b1-helical peptides as promising Middle East respiratory syndrome coronavirus (MERS-CoV) fusion inhibitors","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170526_bib0225","doi-asserted-by":"crossref","first-page":"8734","DOI":"10.1021\/acs.jmedchem.8b00890","article-title":"De novo design of \u03b1-helical lipopeptides targeting viral fusion proteins: a promising strategy for relatively broad-spectrum antiviral drug discovery","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170526_bib0230","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/v11010056","article-title":"Potent MERS-CoV fusion inhibitory peptides identified from HR2 domain in spike protein of bat coronavirus HKU4","volume":"11","author":"Xia","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.peptides.2021.170526_bib0235","doi-asserted-by":"crossref","first-page":"19799","DOI":"10.1021\/acsami.9b04240","article-title":"Novel gold nanorod-based HR1 peptide inhibitor for Middle East respiratory syndrome coronavirus","volume":"11","author":"Huang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.peptides.2021.170526_bib0240","doi-asserted-by":"crossref","first-page":"170328","DOI":"10.1016\/j.peptides.2020.170328","article-title":"In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2","volume":"130","author":"Ling","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170526_bib0245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0250","doi-asserted-by":"crossref","first-page":"e00635","DOI":"10.1128\/JVI.00635-20","article-title":"Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity","volume":"94","author":"Zhu","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2021.170526_bib0255","doi-asserted-by":"crossref","first-page":"e01935","DOI":"10.1128\/mBio.01935-20","article-title":"Inhibition of coronavirus entry in vitro and ex vivo by a lipid-conjugated peptide derived from the SARS-CoV-2 spike glycoprotein HRC domain","volume":"11","author":"Outlaw","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.peptides.2021.170526_bib0260","article-title":"Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets","author":"de Vries","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.peptides.2021.170526_bib0265","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1038\/s41467-020-17986-9","article-title":"A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.peptides.2021.170526_bib0270","doi-asserted-by":"crossref","first-page":"173499","DOI":"10.1016\/j.ejphar.2020.173499","article-title":"Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2","volume":"885","author":"Madadlou","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170526_bib0275","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/ijms19020487","article-title":"Peptide-based membrane fusion inhibitors targeting HCoV-229E spike protein HR1 and HR2 domains","volume":"19","author":"Xia","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.peptides.2021.170526_bib0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.peptides.2021.170526_bib0285","doi-asserted-by":"crossref","first-page":"127377","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.peptides.2021.170526_bib0290","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.peptides.2005.09.006","article-title":"Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase","volume":"27","author":"Gan","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170526_bib0295","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/jm0507678","article-title":"Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors","volume":"49","author":"Zhang","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170526_bib0300","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2009.09.023","article-title":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo","volume":"395","author":"Day","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2021.170526_bib0305","first-page":"22","article-title":"Profiling of substrate-specificity and rational design of broad-spectrum peptidomimetic inhibitors for main proteases of coronaviruses","volume":"20","author":"Chuck","year":"2014","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.peptides.2021.170526_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157340607779317616","article-title":"Inhibitor design for SARS coronavirus main protease based on \u201cdistorted key theory\u201d","volume":"3","author":"Du","year":"2007","journal-title":"Med. Chem."},{"key":"10.1016\/j.peptides.2021.170526_bib0315","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.antiviral.2011.08.001","article-title":"Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease","volume":"92","author":"Zhu","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0320","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1021\/jm200870n","article-title":"Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors","volume":"54","author":"Akaji","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170526_bib0325","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1039\/D0FO00530D","article-title":"In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients","volume":"11","author":"Yao","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.peptides.2021.170526_bib0330","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.virusres.2012.05.017","article-title":"Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2\u2019-O-methyltransferase activity of nsp10\/nsp16 complex","volume":"167","author":"Ke","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0335","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.febslet.2012.11.016","article-title":"Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein","volume":"587","author":"Lo","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.peptides.2021.170526_bib0340","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","article-title":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses","volume":"32","author":"Li","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170526_bib0345","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.imbio.2019.05.004","article-title":"Human \u03b2-defensin 2 is involved in CCR2-mediated Nod2 signal transduction, leading to activation of the innate immune response in macrophages","volume":"224","author":"Kim","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.peptides.2021.170526_bib0350","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12985-018-1035-2","article-title":"Human \u03b2-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity","volume":"15","author":"Kim","year":"2018","journal-title":"Virol. J."},{"key":"10.1016\/j.peptides.2021.170526_bib0355","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.3390\/nu12123741","article-title":"The benefits of vitamin D supplementation for athletes: better performance and reduced risk of COVID-19","volume":"12","author":"Grant","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.peptides.2021.170526_bib0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2010.11.014","article-title":"Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro","volume":"410","author":"Ren","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2021.170526_bib0365","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/mab.2013.0038","article-title":"Screening and antiviral analysis of phages that display peptides with an affinity to subunit C of porcine aminopeptidase","volume":"32","author":"Guo","year":"2013","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"10.1016\/j.peptides.2021.170526_bib0370","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.antiviral.2013.06.015","article-title":"Transmissible gastroenteritis virus: identification of M protein-binding peptide ligands with antiviral and diagnostic potential","volume":"99","author":"Zou","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0375","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11262-015-1234-5","article-title":"Putative phage-display epitopes of the porcine epidemic diarrhea virus S1 protein and their anti-viral activity","volume":"51","author":"Cao","year":"2015","journal-title":"Virus Genes"},{"key":"10.1016\/j.peptides.2021.170526_bib0380","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virusres.2015.04.011","article-title":"Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection","volume":"204","author":"Doki","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0385","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11427-006-0158-7","article-title":"Identification of one peptide which inhibited infectivity of avian infectious bronchitis virus in vitro","volume":"49","author":"Peng","year":"2006","journal-title":"Sci. China C Life Sci."},{"key":"10.1016\/j.peptides.2021.170526_bib0390","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3382\/ps.2009-00461","article-title":"Swine intestine antimicrobial peptides inhibit infectious bronchitis virus infectivity in chick embryos","volume":"89","author":"Sun","year":"2010","journal-title":"Poult. Sci."},{"key":"10.1016\/j.peptides.2021.170526_bib0395","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170082","article-title":"Bacillus subtilis and surfactin inhibit the transmissible gastroenteritis virus from entering the intestinal epithelial cells","volume":"37","author":"Wang","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.peptides.2021.170526_bib0400","doi-asserted-by":"crossref","first-page":"e00809","DOI":"10.1128\/JVI.00809-18","article-title":"Surfactin inhibits membrane fusion during invasion of epithelial cells by enveloped Viruses","volume":"92","author":"Yuan","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2021.170526_bib0405","doi-asserted-by":"crossref","first-page":"e0215227","DOI":"10.1371\/journal.pone.0215227","article-title":"Synthetic surfactin analogues have improved anti-PEDV properties","volume":"14","author":"Yuan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170526_bib0410","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2014.01.010","article-title":"A phage-displayed peptide recognizing porcine aminopeptidase N is a potent small molecule inhibitor of PEDV entry","volume":"456","author":"Meng","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2021.170526_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.11.021","article-title":"Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies","volume":"150","author":"Zhao","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170526_bib0420","doi-asserted-by":"crossref","first-page":"e82081","DOI":"10.1371\/journal.pone.0082081","article-title":"Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170526_bib0425","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virol.2011.05.001","article-title":"Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins","volume":"416","author":"Wang","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2021.170526_bib0430","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2021.170526_bib0435","doi-asserted-by":"crossref","first-page":"31138","DOI":"10.1074\/jbc.M115.654855","article-title":"Antiviral cystine knot \u03b1-amylase inhibitors from alstonia scholaris","volume":"290","author":"Nguyen","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2021.170526_bib0440","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.4142\/jvs.2020.21.e80","article-title":"Antiviral effects of bovine antimicrobial peptide against TGEV in vivo and in vitro","volume":"21","author":"Liang","year":"2020","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.peptides.2021.170526_bib0445","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00705-020-04747-8","article-title":"The antiviral protein viperin interacts with the viral N protein to inhibit proliferation of porcine epidemic diarrhea virus","volume":"165","author":"Wu","year":"2020","journal-title":"Arch. Virol."},{"key":"10.1016\/j.peptides.2021.170526_bib0450","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/v10090507","article-title":"Caerin1.1 suppresses the growth of porcine epidemic diarrhea virus in vitro via direct binding to the virus","volume":"10","author":"Guo","year":"2018","journal-title":"Viruses"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121000346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121000346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:29:43Z","timestamp":1759310983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978121000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":90,"alternative-id":["S0196978121000346"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170526","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral peptides against Coronaviridae family: A review","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170526"}}